JPMorgan Chase & Co. Trims Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

JPMorgan Chase & Co. decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 71.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 570,842 shares of the financial services provider’s stock after selling 1,436,790 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.17% of iShares Biotechnology ETF worth $83,115,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. BNP Paribas Financial Markets boosted its stake in iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth about $9,180,000. Sanctuary Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth about $8,118,000. Finally, DRW Securities LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter worth about $5,990,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.5 %

IBB opened at $132.91 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The business has a 50 day moving average price of $138.87 and a two-hundred day moving average price of $142.02.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.